Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Accumulated Expenses: 2019-2024

Historic Accumulated Expenses for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $475,000.

  • Benitec Biopharma's Accumulated Expenses fell 17.60% to $426,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $426,000, marking a year-over-year decrease of 17.60%. This contributed to the annual value of $475,000 for FY2024, which is 0.64% up from last year.
  • Latest data reveals that Benitec Biopharma reported Accumulated Expenses of $475,000 as of FY2024, which was up 0.64% from $472,000 recorded in FY2023.
  • In the past 5 years, Benitec Biopharma's Accumulated Expenses ranged from a high of $475,000 in FY2024 and a low of $203,000 during FY2020.
  • In the last 3 years, Benitec Biopharma's Accumulated Expenses had a median value of $472,000 in 2023 and averaged $449,000.
  • Data for Benitec Biopharma's Accumulated Expenses shows a peak YoY spiked of 44.93% (in 2022) over the last 5 years.
  • Over the past 5 years, Benitec Biopharma's Accumulated Expenses (Yearly) stood at $203,000 in 2020, then soared by 35.96% to $276,000 in 2021, then soared by 44.93% to $400,000 in 2022, then rose by 18.00% to $472,000 in 2023, then climbed by 0.64% to $475,000 in 2024.